| Product NDC: | 52549-4147 |
| Proprietary Name: | Meprobamate |
| Non Proprietary Name: | Meprobamate |
| Active Ingredient(s): | 200 mg/1 & nbsp; Meprobamate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52549-4147 |
| Labeler Name: | Taro Pharmaceutical Industries Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200998 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110523 |
| Package NDC: | 52549-4147-3 |
| Package Description: | 1000 TABLET in 1 BOTTLE (52549-4147-3) |
| NDC Code | 52549-4147-3 |
| Proprietary Name | Meprobamate |
| Package Description | 1000 TABLET in 1 BOTTLE (52549-4147-3) |
| Product NDC | 52549-4147 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Meprobamate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110523 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceutical Industries Ltd. |
| Substance Name | MEPROBAMATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |